New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
78.02+0.33 (+0.42%)
At close: 04:00PM EDT
78.29 +0.27 (+0.35%)
Pre-market: 05:18AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 114.22B
Enterprise value 122.89B
Trailing P/E 65.29
Forward P/E 33.33
PEG ratio (5-yr expected) 1.92
Price/sales (ttm)7.78
Price/book (mrq)5.73
Enterprise value/revenue 8.36
Enterprise value/EBITDA 33.83

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 347.11%
S&P500 52-week change 323.28%
52-week high 378.98
52-week low 348.35
50-day moving average 375.58
200-day moving average 363.99

Share statistics

Avg vol (3-month) 35.9M
Avg vol (10-day) 34.41M
Shares outstanding 51.47B
Implied shares outstanding 61.47B
Float 81.47B
% held by insiders 10.19%
% held by institutions 192.69%
Shares short (28 Jun 2024) 411.25M
Short ratio (28 Jun 2024) 42.02
Short % of float (28 Jun 2024) 40.77%
Short % of shares outstanding (28 Jun 2024) 40.77%
Shares short (prior month 31 May 2024) 413.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 306 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.05%
Operating margin (ttm)17.97%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)9.25%

Income statement

Revenue (ttm)14.71B
Revenue per share (ttm)10.06
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA 3.74B
Net income avi to common (ttm)1.76B
Diluted EPS (ttm)1.19
Quarterly earnings growth (yoy)57.30%

Balance sheet

Total cash (mrq)2.33B
Total cash per share (mrq)1.58
Total debt (mrq)11B
Total debt/equity (mrq)54.55%
Current ratio (mrq)1.66
Book value per share (mrq)13.56

Cash flow statement

Operating cash flow (ttm)2.48B
Levered free cash flow (ttm)1.65B